Gate Neurosciences
Carmel, US · Founded 2018 · Delaware corporation
Founders & leadership
Gate Neurosciences was founded in 2018 by Derek Small.
DS
Derek SmallFounder
MM
Michael McCullyExecutive
Reported raises · per SEC filings
Form D private placements$16.1M disclosed across 2 rounds · 2020–2021
▶$15MraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael McCullyExecutive Officer, Director
- Derek SmallExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.1MraisedAug 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedAug 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael McCullyExecutive Officer
- Derek SmallExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.1M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Gate Neurosciences?
- Gate Neurosciences was founded by Derek Small in 2018.
- How much funding has Gate Neurosciences raised?
- Gate Neurosciences has disclosed $16.1M raised across 2 rounds.
- Where is Gate Neurosciences headquartered?
- Gate Neurosciences is headquartered in Carmel, US.